Bacterial neuraminidase and altered immunological behavior of treated mammalian cells.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D001419:Bacteria / Q000201:enzymology* / Q000472:pathogenicity; D002478:Cells, Cultured / Q000187:drug effects / Q000276:immunology*; D008322:Mammals; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000276:immunology / Q000378:metabolism; D009439:Neuraminidase / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D012794:Sialic Acids / Q000378:metabolism; D013045:Species Specificity; D014780:Viruses / Q000201:enzymology
D000912:Antibodies, Neoplasm; D012794:Sialic Acids; D009439:Neuraminidase